Filing Details
- Accession Number:
- 0001801170-25-000170
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2025-07-10 19:24:38
- Reporting Period:
- 2024-09-13
- Filing Date:
- 2025-07-10
- Accepted Time:
- 2025-07-10 19:24:38
- Original Submission Date:
- 2024-09-17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1801170 | Clover Health Investments Corp. | CLOV | Hospital & Medical Service Plans (6324) | 981515192 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1971702 | Conrad Wai | C/O Clover Health Investments, Corp. Not Applicable Wilmington DE 19801 | Ceo, Counterpart Health | No | Yes | No | No |
Transaction Summary
| Sold: | 15,203 shares | Avg. Price: $3.26 | Total Value: $49,561.78 |
| Number of Shares After Transactions: | 1,613,498 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2024-09-13 | 379,866 | $0.00 | 1,699,767 | No | 4 | A | Direct | |
| Class A Common Stock | Disposition | 2025-07-08 | 15,203 | $3.26 | 1,613,498 | No | 4 | S | Indirect | By Trust. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Indirect | By Trust. |
Footnotes
- Represents restricted stock units ("RSUs"), each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units will vest on October 31, 2025, subject to the Reporting Person's continued employment on such vesting date. This Amendment is being filed to reflect the full number of RSUs that were achieved.
- Number reflects total directly held Class A Common Stock taking into account the amended number and subsequent transactions through July 10, 2025.
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.27, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.
Billionaire Hedge Funds
